James Hill trades CVS Health Corporation stock in Hill Family Fund

Published 06/02/2025, 11:28
James Hill trades CVS Health Corporation stock in Hill Family Fund

In a recent congressional trade report, it was revealed that James French Hill, the representative for Arkansas’s 2nd congressional district, has made a significant trade involving the stock of CVS Health Corporation (NYSE:CVS), currently trading at $55.69 with a market capitalization of $70.29 billion.

The transaction, which took place on January 31, 2025, involved the sale of CVS Health Corporation common stock. The dollar value of this trade falls within the range of $15,001 to $50,000. This information was made public on the same date as the transaction. According to InvestingPro, CVS has maintained dividend payments for 55 consecutive years and currently shows a GOOD financial health score, with 10+ additional ProTips available to subscribers.

The trade was conducted through the Hill Family Fund, previously registered as the Jay F. Hill Charitable Trust, which was established on December 12, 1990. This fund is a significant investment vehicle for the congressman, and the CVS Health Corporation stock was a subholding of this fund.

The CVS Health Corporation is a healthcare company that operates pharmacies across the country, providing a wide range of health services. The sale of this stock by Representative Hill is a notable transaction given the company’s prominence in the healthcare sector.

While the reasons behind the sale are not known, this transaction provides insight into the investment activities of one of our congressional representatives. As always, it is important for investors to stay informed about these trades, as they can provide valuable information about market trends and the financial decisions of influential individuals. InvestingPro’s Fair Value analysis suggests CVS is currently undervalued, with analysts setting price targets ranging from $48.01 to $93.00, making it an interesting stock for value investors to monitor.

This report is part of the ongoing transparency efforts in congress to ensure the public is aware of the financial activities of its representatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.